Clinical Trial Update: Open-label Pilot Study of Abatacept for the Treatment of Vitiligo [Phase 1]

View source ↗

Summary

An open-label Phase 1 pilot study is investigating abatacept as a treatment for vitiligo. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Abatacept (Orencia) (abatacept)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Vitiligo | Phase 1 | Status: UNKNOWN